Radiotherapy compliance is maintained with hypofractionation and concurrent cetuximab in locally advanced head and neck cancer

Received 20 March 2009; received in revised form 9 May 2009; accepted 10 May 2009. published online 15 June 2009.

No abstract is available. To read the body of this article, please view the Full Text online.

Cancer Centre, Queen Elizabeth Hospital, Birmingham, UK

PII: S0167-8140(09)00238-2

doi:10.1016/j.radonc.2009.05.005

48 of 52